ACS Chemical Neuroscience · 2015 · 50 citations · 38 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryPain MedicineSynthetic Medicinal ChemistryAnalgesic PharmacologyDrug-receptor InteractionsLigand BindingOpioid AnalgesicsOpioid PharmacologyReceptor PharmacologyAnalgesic Drug DevelopmentBinding AssaysDelta Opioid Receptor PharmacologyOpioid Receptor AgonistsOpioid Receptor BindingPartial Agonist PotencyRadioligand Binding AssaysReceptor Binding Assays
We report a novel approach to synthesize carfentanil amide analogues utilizing the isocyanide-based four-component Ugi multicomponent reaction. A small library of bis-amide analogues of carfentanil was created using N-alkylpiperidones, aniline, propionic acid, and various aliphatic isocyanides. Our lead compound showed high affinity for mu (MOR) and delta opioid receptors (DOR) with no appreciable affinity for kappa (KOR) receptors in radioligand binding assays. The compound was found to be a mixed MOR agonist/partial DOR agonist in [(35)S]GTPγS functional assays, and it showed moderate analgesic potency in vivo. The compound showed no visible signs of physical dependence or constipation in mice. In addition, it produced less respiratory depression than morphine. Most mixed MOR/DOR opioids reported in the literature are peptides and thereby systemically inactive. Our approach utilizing a multicomponent reaction has the promise to deliver potent and efficacious small-molecule analgesics with potential clinical utility.
38
Opioid Complications and Side Effects
Ramsin Benyamin · Pain Physician · 2008 · 2.2K citations
Peptide Folding: When Simulation Meets Experiment
Xavier Daura, Karl Gademann, Bernhard Jaun et al. · Angewandte Chemie International Edition · 1999 · 2K citations
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Aashish Manglik, Andrew C. Kruse, Tong Sun Kobilka et al. · Nature · 2012 · 1.4K citations